Glenmede Trust’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-14,200
Closed -$158K – 1989
2018
Q1
$158K Hold
14,200
– – ﹤0.01% 1258
2017
Q4
$158K Sell
14,200
-4,000
-22% -$42.5K ﹤0.01% 1258
2017
Q3
$185K Buy
18,200
+700
+4% +$6.63K ﹤0.01% 1251
2017
Q2
$113K Hold
17,500
– – ﹤0.01% 1349
2017
Q1
$113K Sell
17,500
-2,100
-11% -$15K ﹤0.01% 1349
2016
Q4
$115K Hold
19,600
– – ﹤0.01% 1362
2016
Q3
$141K Sell
19,600
-3,200
-14% -$19.2K ﹤0.01% 1303
2016
Q2
$106K Hold
22,800
– – ﹤0.01% 1354
2016
Q1
$118K Hold
22,800
– – ﹤0.01% 1289
2015
Q4
$175K Hold
22,800
– – ﹤0.01% 1206
2015
Q3
$138K Buy
22,800
+7,200
+46% +$60K ﹤0.01% 1289
2015
Q2
$184K Hold
15,600
– – ﹤0.01% 1245
2015
Q1
$316K Hold
15,600
– – ﹤0.01% 1123
2014
Q4
$256K Buy
+15,600
New +$291K ﹤0.01% 1194

Other funds holding CSTM

Glenmede Trust's CSTM Position: Q2 2018 in Review

Glenmede Trust sold out of Constellium (CSTM) in Q2 2018, closing a stake of 14,200 shares — an estimated $158K sold.

Glenmede Trust first reported a position in CSTM in Q4 2014 and held it in 14 quarters. The position peaked at $316K in Q1 2015. 148 funds tracked by Wall St. Rank hold CSTM as of Q2 2018.

  • Glenmede Trust reported no remaining Constellium position as of Q2 2018 after selling out during the quarter.
  • Glenmede Trust sold 14,200 Constellium shares in Q2 2018, an estimated $158K.
  • Glenmede Trust first reported a position in Constellium in Q4 2014 and held it in 14 quarters.
  • Glenmede Trust's Constellium position peaked at $316K in Q1 2015.
  • 148 funds tracked by Wall St. Rank held Constellium as of Q2 2018.

Based on Glenmede Trust's 13F filing for Q2 2018, filed 15 Aug 2018.